The fixed combination of levofloxacin and dexamethasone eye drops developed by NTC is now available in Mexico and South-East Asia (Thailand, Singapore, Philippines, Hong Kong)

NTC announces the submission of the marketing authorisation application through the European Decentralised Procedure (DCP) for its development product NTC015 (Kleerkol^®) for bowel preparation for colonoscopy

NTC Srl, an R&D focused pharmaceutical company headquartered in Italy, with distribution partners in over 100 countries, announced today that it has entered into an exclusive agreement with Théa for NTC026